A detailed history of Lcm Capital Management Inc transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Lcm Capital Management Inc holds 813,159 shares of AMRN stock, worth $447,237. This represents 0.3% of its overall portfolio holdings.

Number of Shares
813,159
Previous 813,159 -0.0%
Holding current value
$447,237
Previous $561,000 8.73%
% of portfolio
0.3%
Previous 0.35%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$0.63 - $1.07 $3,150 - $5,350
5,000 Added 0.62%
813,159 $561,000
Q1 2024

May 06, 2024

BUY
$0.82 - $1.35 $55,760 - $91,800
68,000 Added 9.19%
808,159 $719,000
Q4 2023

Feb 05, 2024

BUY
$0.66 - $0.91 $23,760 - $32,760
36,000 Added 5.11%
740,159 $643,000
Q3 2023

Nov 07, 2023

BUY
$0.85 - $1.43 $304,300 - $511,940
358,000 Added 103.42%
704,159 $647,000
Q2 2023

Aug 11, 2023

BUY
$1.12 - $1.49 $16,800 - $22,350
15,000 Added 4.53%
346,159 $411,000
Q1 2023

May 01, 2023

BUY
$1.19 - $2.19 $59,500 - $109,500
50,000 Added 17.78%
331,159 $496,000
Q4 2022

Jan 24, 2023

BUY
$1.07 - $1.34 $34,152 - $42,770
31,918 Added 12.81%
281,159 $0
Q3 2022

Oct 14, 2022

BUY
$1.09 - $1.67 $11,990 - $18,370
11,000 Added 4.62%
249,241 $272,000
Q2 2022

Jul 28, 2022

BUY
$1.13 - $3.69 $98,309 - $321,030
87,000 Added 57.52%
238,241 $355,000
Q1 2022

Apr 18, 2022

BUY
$2.85 - $3.73 $149,910 - $196,198
52,600 Added 53.32%
151,241 $530,000
Q4 2021

Jan 24, 2022

SELL
$3.24 - $5.18 $18,468 - $29,526
-5,700 Reduced 5.46%
98,641 $332,000
Q3 2021

Oct 15, 2021

SELL
$3.94 - $5.84 $9,924 - $14,710
-2,519 Reduced 2.36%
104,341 $532,000
Q2 2021

Jul 21, 2021

BUY
$4.26 - $6.5 $279,030 - $425,750
65,500 Added 158.37%
106,860 $468,000
Q1 2021

May 17, 2021

SELL
$5.03 - $8.8 $6,287 - $11,000
-1,250 Reduced 2.93%
41,360 $257,000
Q4 2020

May 12, 2021

BUY
$4.04 - $5.31 $172,144 - $226,259
42,610 New
42,610 $208,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Lcm Capital Management Inc Portfolio

Follow Lcm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lcm Capital Management Inc with notifications on news.